Publikationen in Zusammenarbeit mit Forschern von Centro de Investigacion Biomedica en Red de Salud Mental (10)

2023

  1. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

2022

  1. The effect of early life events on glucose levels in first-episode psychosis

    Frontiers in Endocrinology, Vol. 13

  2. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

2021

  1. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2018

  1. Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis

    Schizophrenia Research, Vol. 193, pp. 188-196

2017

  1. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422

2013

  1. Evidencias de efcacia de la rehabilitación cognitiva en psicosis y esquizofrenia con el programa rehacop. Réply

    Revista de Neurologia

2012

  1. An explanatory model of quality of life in schizophrenia: The role of processing speed and negative symptoms

    Actas Espanolas de Psiquiatria, Vol. 40, Núm. 1, pp. 10-18

  2. Efficiency of cognitive rehabilitation with REHACOP in chronic treatment resistant Hispanic patients

    NeuroRehabilitation, Vol. 30, Núm. 1, pp. 65-74

  3. REHACOP: Programa de rehabilitación cognitiva en psicosis

    Revista de Neurologia, Vol. 54, Núm. 6, pp. 337-342